A single IV dose corrected thalassemia in mice — no drug selection required

Key Findings

🛡️ A Stress-Blocker That Keeps Edited Stem Cells Cleaner

• Temporarily inhibiting a stress-signaling enzyme called p38 MAPK during ex vivo CRISPR editing of blood stem cells reduced micronuclei — a marker of chromosomal damage — without increasing other genomic alterations like translocations or large deletions.
• Long-term transplant experiments followed by whole-exome sequencing showed treated cells carried a lower overall mutation burden, suggesting the intervention improves stem cell fitness without hiding new genomic problems.

✂️ Hybrid DNA-RNA Guides Cut More Precisely In Vivo

• Replacing standard RNA guide molecules with hybrid RNA-DNA guides for the Cas12a editing system, delivered in lipid nanoparticles, produced near-complete knockdown of three liver proteins linked to cholesterol disease and a fatal protein-misfolding condition — with no detectable off-target edits in mice.
• No liver toxicity, no chronic immune activation, and no editing detected outside liver tissue at high doses, suggesting the specificity gain doesn't come at an obvious safety cost.

🧠 A Hidden Regulator of Human Brain Expansion

• Using CRISPR to knock out the gene HOPX in human stem cell-derived brain organoids, researchers found that HOPX loss reduced the size of a key developmental zone, cut neuronal output, and pushed progenitor cells to become support cells prematurely.
• The effect was tied to impaired activity in a growth-signaling pathway, suggesting HOPX helps maintain the window during which human cortical progenitors produce neurons rather than glia.

🔬 Schizophrenia Risk Traced to a Common Variant in a Gene Regulator

• A large CRISPR screen silenced 333 regulatory DNA regions in stem cell-derived neurons to find which ones control genes linked to schizophrenia. Separately, a prime editing screen tested specific genetic variants — and one common variant in the promoter of SV2A, present in about 3.6% of the population, was found to boost that gene's activity in neurons.
• The finding maps a non-coding genetic signal to a specific molecular mechanism, a rare outcome in psychiatric genetics where most risk variants sit in genomic regions with no clear function.

🧬 A Diabetes Risk Gene Decoded in Human Islet Cells

• Researchers used CRISPR to engineer two versions of a known type 1 diabetes risk gene — one protective variant and one risk variant — into human stem cells, then grew them into functional pancreatic islets.
• When exposed to inflammatory signals or a virus linked to diabetes onset, islets carrying the protective variant showed less cell death, lower viral load, better mitochondrial function, and less impairment of insulin secretion compared to those with the risk variant.

🌱 Drought-Tolerant Alfalfa Without a Yield Sacrifice

• A genome-wide association study in alfalfa pinpointed a transcription factor called MsCBF8 as a positive regulator of drought tolerance. CRISPR knockouts confirmed the gene's role, and overexpression lines showed improved water-use efficiency, better antioxidant defense, and maintained photosynthesis — without reducing plant growth.
• The gene works by directly activating a downstream target involved in a protective sugar pathway, giving researchers a two-node circuit to target in breeding programs.